|
Disease |
|
|
|
Detail |
| hsa-miR-130a |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-let-7f-2 |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-let-7g |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-let-7c |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-let-7d |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-let-7e |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-let-7a-1 |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-let-7a-2 |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-let-7a-3 |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-let-7b |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-132 |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-136 |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-214 |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-594 |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-122a |
|
Causal |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-181a-2 |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-181c |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-141 |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-142-3p |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-142-5p |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-143 |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-199a-1-5p |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-199a-2-5p |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-199b |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-200b |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-223 |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-181a-1 |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-150 |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-124a-2 |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-146a |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-195 |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-122a |
|
Unspecified |
Real-time expression profiling of microRNA precursors in human cancer cell lines. |
2005 |
|
|
|
|
|
|
| hsa-miR-125b-2 |
|
Unspecified |
Identification of metastasis-related microRNAs in hepatocellular carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-let-7g |
|
Unspecified |
Identification of metastasis-related microRNAs in hepatocellular carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-15a |
|
Unspecified |
Identification of metastasis-related microRNAs in hepatocellular carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-207 |
|
Unspecified |
Identification of metastasis-related microRNAs in hepatocellular carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-219-1 |
|
Unspecified |
Identification of metastasis-related microRNAs in hepatocellular carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-9-2 |
|
Unspecified |
Identification of metastasis-related microRNAs in hepatocellular carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-1-2 |
|
Unspecified |
Identification of metastasis-related microRNAs in hepatocellular carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-122a |
|
Unspecified |
Identification of metastasis-related microRNAs in hepatocellular carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-185 |
|
Unspecified |
Identification of metastasis-related microRNAs in hepatocellular carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-19a |
|
Unspecified |
Identification of metastasis-related microRNAs in hepatocellular carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-30a |
|
Unspecified |
Identification of metastasis-related microRNAs in hepatocellular carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-30c-1 |
|
Unspecified |
Identification of metastasis-related microRNAs in hepatocellular carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-30e |
|
Unspecified |
Identification of metastasis-related microRNAs in hepatocellular carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-338 |
|
Unspecified |
Identification of metastasis-related microRNAs in hepatocellular carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-34a |
|
Unspecified |
Identification of metastasis-related microRNAs in hepatocellular carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-148b |
|
Unspecified |
Identification of metastasis-related microRNAs in hepatocellular carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-124a-2 |
|
Unspecified |
Identification of metastasis-related microRNAs in hepatocellular carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-126 |
|
Unspecified |
Identification of metastasis-related microRNAs in hepatocellular carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-148a |
|
Unspecified |
Identification of metastasis-related microRNAs in hepatocellular carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-194 |
|
Unspecified |
Identification of metastasis-related microRNAs in hepatocellular carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-20a |
|
Unspecified |
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. |
2006 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. |
2006 |
|
|
|
|
|
|
| hsa-miR-212 |
|
Unspecified |
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. |
2006 |
|
|
|
|
|
|
| hsa-miR-215 |
|
Unspecified |
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. |
2006 |
|
|
|
|
|
|
| hsa-miR-219-1 |
|
Unspecified |
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. |
2006 |
|
|
|
|
|
|
| hsa-miR-172a-2 |
|
Unspecified |
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. |
2006 |
|
|
|
|
|
|
| hsa-miR-17-3p |
|
Unspecified |
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. |
2006 |
|
|
|
|
|
|
| hsa-miR-93 |
|
Unspecified |
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. |
2006 |
|
|
|
|
|
|
| hsa-miR-106b-1 |
|
Unspecified |
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. |
2006 |
|
|
|
|
|
|
| hsa-miR-122a |
|
Unspecified |
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. |
2006 |
|
|
|
|
|
|
| hsa-miR-123 |
|
Unspecified |
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. |
2006 |
|
|
|
|
|
|
| hsa-miR-130a-1 |
|
Unspecified |
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. |
2006 |
|
|
|
|
|
|
| hsa-miR-130b-1 |
|
Unspecified |
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. |
2006 |
|
|
|
|
|
|
| hsa-miR-23a |
|
Unspecified |
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. |
2006 |
|
|
|
|
|
|
| hsa-miR-23b |
|
Unspecified |
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. |
2006 |
|
|
|
|
|
|
| hsa-miR-24 |
|
Unspecified |
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. |
2006 |
|
|
|
|
|
|
| hsa-miR-26a-1 |
|
Unspecified |
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. |
2006 |
|
|
|
|
|
|
| hsa-miR-26a-2 |
|
Unspecified |
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. |
2006 |
|
|
|
|
|
|
| hsa-miR-320-2 |
|
Unspecified |
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. |
2006 |
|
|
|
|
|
|
| hsa-miR-328-1 |
|
Unspecified |
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. |
2006 |
|
|
|
|
|
|
| hsa-miR-17-5p |
|
Unspecified |
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. |
2006 |
|
|
|
|
|
|
| hsa-miR-101b-2 |
|
Unspecified |
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. |
2006 |
|
|
|
|
|
|
| hsa-miR-103-2 |
|
Unspecified |
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. |
2006 |
|
|
|
|
|
|
| hsa-miR-106a-1 |
|
Unspecified |
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. |
2006 |
|
|
|
|
|
|
| hsa-miR-125b-1 |
|
Unspecified |
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. |
2006 |
|
|
|
|
|
|
| hsa-miR-125b-2 |
|
Unspecified |
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. |
2006 |
|
|
|
|
|
|
| hsa-miR-192-1 |
|
Unspecified |
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. |
2006 |
|
|
|
|
|
|
| hsa-miR-192-2 |
|
Unspecified |
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. |
2006 |
|
|
|
|
|
|
| hsa-miR-20a |
|
Unspecified |
Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. |
2006 |
|
|
|
|
|
|
| hsa-miR-99a |
|
Unspecified |
Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. |
2006 |
|
|
|
|
|
|
| hsa-miR-199a |
|
Unspecified |
Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. |
2006 |
|
|
|
|
|
|
| hsa-miR-199a* |
|
Unspecified |
Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. |
2006 |
|
|
|
|
|
|
| hsa-miR-200a |
|
Unspecified |
Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. |
2006 |
|
|
|
|
|
|
| hsa-miR-224 |
|
Unspecified |
Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. |
2006 |
|
|
|
|
|
|
| hsa-miR-18 |
|
Unspecified |
Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. |
2006 |
|
|
|
|
|
|
| hsa-miR-125a |
|
Unspecified |
Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. |
2006 |
|
|
|
|
|
|
| hsa-miR-195 |
|
Unspecified |
Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. |
2006 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. |
2007 |
|
|
|
|
|
|
| hsa-miR-9 |
|
Causal |
MicroRNA-9 reduces cell invasion and E-cadherin secretion in SK-Hep-1 cell. |
2009 |
|
|
|
|
|
|
| hsa-miR-122a |
|
Causal |
MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. |
2009 |
|
|
|
|
|
|
| hsa-miR-181a-1 |
|
Causal |
Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. |
2009 |
|
|
|
|
|
|
| hsa-miR-181a-2 |
|
Causal |
Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. |
2009 |
|
|
|
|
|
|
| hsa-miR-181b-1 |
|
Causal |
Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. |
2009 |
|
|
|
|
|
|
| hsa-miR-181b-2 |
|
Causal |
Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. |
2009 |
|
|
|
|
|
|
| hsa-miR-181c |
|
Causal |
Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. |
2009 |
|
|
|
|
|
|
| hsa-miR-122 |
|
Unspecified |
Loss of miR-122 expression in liver cancer correlates with suppression of the
hepatic phenotype and gain of metastatic properties. |
2009 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Causal |
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. |
2009 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Causal |
Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice. |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice. |
2009 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice. |
2009 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Unspecified |
Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice. |
2009 |
|
|
|
|
|
|
| hsa-miR-122 |
|
Unspecified |
Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice. |
2009 |
|
|
|
|
|
|
| hsa-miR-26a |
|
Unspecified |
MicroRNA expression, survival, and response to interferon in liver cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-26b |
|
Unspecified |
MicroRNA expression, survival, and response to interferon in liver cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-124 |
|
Causal |
miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma |
2009 |
|
|
|
|
|
|
| hsa-miR-203 |
|
Causal |
miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma |
2009 |
|
|
|
|
|
|
| hsa-miR-500 |
|
Unspecified |
MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma |
2009 |
|
|
|
|
|
|
| hsa-miR-137 |
|
Unspecified |
Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. |
2008 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. |
2008 |
|
|
|
|
|
|
| hsa-miR-214 |
|
Unspecified |
Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. |
2008 |
|
|
|
|
|
|
| hsa-miR-216 |
|
Unspecified |
Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. |
2008 |
|
|
|
|
|
|
| hsa-miR-9 |
|
Unspecified |
Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. |
2008 |
|
|
|
|
|
|
| hsa-miR-9* |
|
Unspecified |
Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. |
2008 |
|
|
|
|
|
|
| hsa-miR-96 |
|
Unspecified |
Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. |
2008 |
|
|
|
|
|
|
| hsa-miR-182 |
|
Unspecified |
Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. |
2008 |
|
|
|
|
|
|
| hsa-miR-182* |
|
Unspecified |
Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. |
2008 |
|
|
|
|
|
|
| hsa-miR-183 |
|
Unspecified |
Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. |
2008 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. |
2008 |
|
|
|
|
|
|
| hsa-miR-139 |
|
Unspecified |
Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. |
2008 |
|
|
|
|
|
|
| hsa-miR-224 |
|
Causal |
Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. |
2008 |
|
|
|
|
|
|
| hsa-miR-25 |
|
Unspecified |
Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. |
2008 |
|
|
|
|
|
|
| hsa-miR-301 |
|
Unspecified |
Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. |
2008 |
|
|
|
|
|
|
| hsa-miR-324-5p |
|
Unspecified |
Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. |
2008 |
|
|
|
|
|
|
| hsa-miR-374 |
|
Unspecified |
Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. |
2008 |
|
|
|
|
|
|
| hsa-miR-186 |
|
Unspecified |
Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. |
2008 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. |
2008 |
|
|
|
|
|
|
| hsa-miR-151 |
|
Unspecified |
Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. |
2008 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Unspecified |
Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. |
2008 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Unspecified |
Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. |
2008 |
|
|
|
|
|
|
| hsa-miR-122a |
|
Unspecified |
MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. |
2008 |
|
|
|
|
|
|
| hsa-miR-126 |
|
Unspecified |
MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. |
2008 |
|
|
|
|
|
|
| hsa-miR-223 |
|
Causal |
MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. |
2008 |
|
|
|
|
|
|
| hsa-miR-31 |
|
Unspecified |
MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. |
2008 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. |
2008 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Unspecified |
MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. |
2008 |
|
|
|
|
|
|
| hsa-miR-96 |
|
Unspecified |
MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. |
2008 |
|
|
|
|
|
|
| hsa-miR-126* |
|
Unspecified |
MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. |
2008 |
|
|
|
|
|
|
| hsa-miR-224 |
|
Unspecified |
MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. |
2008 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Causal |
MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-23a |
|
Causal |
Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells. |
2008 |
|
|
|
|
|
|
| hsa-miR-24-2 |
|
Causal |
Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells. |
2008 |
|
|
|
|
|
|
| hsa-miR-27a |
|
Causal |
Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells. |
2008 |
|
|
|
|
|
|
| hsa-miR-1 |
|
Causal |
Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. |
2008 |
|
|
|
|
|
|
| hsa-miR-34a |
|
Causal |
miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. |
2009 |
|
|
|
|
|
|
| hsa-miR-17-5p |
|
Causal |
Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. |
2008 |
|
|
|
|
|
|
| hsa-miR-18a |
|
Causal |
Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. |
2008 |
|
|
|
|
|
|
| hsa-miR-19a |
|
Causal |
Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. |
2008 |
|
|
|
|
|
|
| hsa-miR-19b |
|
Causal |
Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. |
2008 |
|
|
|
|
|
|
| hsa-miR-20a |
|
Causal |
Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. |
2008 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. |
2008 |
|
|
|
|
|
|
| hsa-miR-92a |
|
Causal |
Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. |
2008 |
|
|
|
|
|
|
| hsa-miR-122 |
|
Causal |
miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines.
|
2008 |
|
|
|
|
|
|
| hsa-miR-146a |
|
Causal |
A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma.
|
2008 |
|
|
|
|
|
|
| hsa-let-7a |
|
Causal |
Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3. |
2008 |
|
|
|
|
|
|
| hsa-miR-101 |
|
Causal |
MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma. |
2009 |
|
|
|
|
|
|
| hsa-miR-127 |
|
Causal |
Down-regulation of the microRNAs miR-34a, miR-127, and miR-200b in rat liver during hepatocarcinogenesis induced by a methyl-deficient diet. |
2008 |
|
|
|
|
|
|
| hsa-miR-16a |
|
Causal |
Down-regulation of the microRNAs miR-34a, miR-127, and miR-200b in rat liver during hepatocarcinogenesis induced by a methyl-deficient diet. |
2008 |
|
|
|
|
|
|
| hsa-miR-200b |
|
Causal |
Down-regulation of the microRNAs miR-34a, miR-127, and miR-200b in rat liver during hepatocarcinogenesis induced by a methyl-deficient diet. |
2008 |
|
|
|
|
|
|
| hsa-miR-34a |
|
Causal |
Down-regulation of the microRNAs miR-34a, miR-127, and miR-200b in rat liver during hepatocarcinogenesis induced by a methyl-deficient diet. |
2008 |
|
|
|
|
|
|
| hsa-miR-101 |
|
Causal |
MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. |
2009 |
|
|
|
|
|
|
| hsa-let-7d |
|
Unspecified |
Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. |
2009 |
|
|
|
|
|
|
| hsa-miR-1 |
|
Unspecified |
Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. |
2009 |
|
|
|
|
|
|
| hsa-miR-133a |
|
Unspecified |
Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. |
2009 |
|
|
|
|
|
|
| hsa-miR-205 |
|
Unspecified |
Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. |
2009 |
|
|
|
|
|
|
| hsa-miR-16 |
|
Causal |
Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in
human cancer cells. |
2009 |
|
|
|
|
|
|
| hsa-miR-195 |
|
Causal |
MicroRNA-195 suppresses tumorigenicity and regulates G(1)/S transition of human hepatocellular carcinoma cells. |
2009 |
|
|
|
|
|
|
| hsa-miR-143 |
|
Causal |
Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. |
2009 |
|
|
|
|
|
|
| hsa-let-7a |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|
| hsa-miR-107 |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|
| hsa-miR-122a |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|
| hsa-miR-124a |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|
| hsa-miR-125a |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|
| hsa-miR-125b |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|
| hsa-miR-126 |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|
| hsa-miR-126* |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|
| hsa-miR-128b |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|
| hsa-miR-129 |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|
| hsa-miR-130a |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|
| hsa-miR-143 |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|
| hsa-miR-152 |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|
| hsa-miR-15a |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|
| hsa-miR-16 |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|
| hsa-miR-17-5p |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|
| hsa-miR-185 |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|
| hsa-miR-194 |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|
| hsa-miR-195 |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|
| hsa-miR-199a |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|
| hsa-miR-200a |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|
| hsa-miR-205 |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|
| hsa-miR-207 |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|
| hsa-miR-224 |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|
| hsa-miR-24 |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|
| hsa-miR-25 |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|
| hsa-miR-27a |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|
| hsa-miR-338 |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|
| hsa-miR-106b |
|
Causal |
Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. |
2009 |
|
|
|
|
|
|
| hsa-miR-18 |
|
Unspecified |
Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. |
2009 |
|
|
|
|
|
|
| hsa-miR-25 |
|
Causal |
Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. |
2009 |
|
|
|
|
|
|
| hsa-miR-93 |
|
Causal |
Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. |
2009 |
|
|
|
|
|
|
| hsa-miR-122 |
|
Causal |
MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to Sorafenib |
2009 |
|
|
|
|
|
|
| hsa-miR-23b |
|
Causal |
MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. |
2009 |
|
|
|
|
|
|
| hsa-miR-26a |
|
Causal |
Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. |
2009 |
|
|
|
|
|
|